Filing Details
- Accession Number:
- 0001437749-24-008707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-20 16:38:32
- Reporting Period:
- 2024-03-18
- Accepted Time:
- 2024-03-20 16:38:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763581 | Mark Schoenberg | 400 Alexander Park Drive Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2024-03-18 | 12,000 | $14.05 | 139,437 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- A portion of the cash receipts will be used for federal income tax purposes
Billionaire Hedge Funds
